Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 6/2020

27.06.2020 | Case Report

Rare coincidence of intraductal papillary mucinous neoplasm and type 1 autoimmune pancreatitis

verfasst von: Rei Suzuki, Ryo Okada, Makoto Muto, Tadayuki Takagi, Mitsuru Sugimoto, Hiroki Irie, Jun Nakamura, Mika Takasumi, Tsunetaka Kato, Minami Hashimoto, Kenji Notohara, Osamu Suzuki, Yuko Hashimoto, Takuto Hikichi, Shigeru Marubashi, Hiromasa Ohira

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

The present case involved a 60-year-old man with autoimmune pancreatitis (AIP). While his AIP was in remission for 6 years, a follow-up CE-CT revealed a dilated main pancreatic duct (MPD) and an enhanced mural nodule. Fluorodeoxyglucose uptake was positive on positron emission tomography. Endoscopic retrograde pancreatography showed a filling defect of the MPD, and pancreatoscopy revealed a nodule partially covered with papillary lesions. Although a repeat biopsy revealed no evidence of malignancy, we speculated that there was a high likelihood of main-duct-type intraductal papillary mucinous neoplasm (IPMN)-derived carcinoma concomitant with AIP. Subsequently, the patient underwent subtotal stomach-preserving pancreaticoduodenectomy. A surgical specimen showed a 35 mm protuberant papillary lesion with abundant stroma, located in the main duct of the pancreas. Further histological evaluation revealed that the nodule was predominantly composed of IPMN with low-grade dysplasia, which was accompanied by abundant IgG4-positive lymphoplasmacytic infiltration, and fibrosis existed predominantly around the IPMN. The epithelium of the cyst showed mucinous hyperplasia with focal papillary structures of gastric phenotype (MUC5A+, MUC6+, MUC1−, MUC2−, CDX−). After surgical resection, we did not find any imaging evidence suggesting a recurrent tumor and AIP relapse in the remnant pancreas. In conclusion, we report a case of IPMN coincidentally found in a patient with type 1 AIP. Active AIP may exaggerate the morphology of IPMN, and careful evaluation should be performed to select appropriate management.
Literatur
1.
Zurück zum Zitat Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–6 (quiz 934).PubMed Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–6 (quiz 934).PubMed
2.
Zurück zum Zitat Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610–7.PubMed Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610–7.PubMed
3.
Zurück zum Zitat Naitoh I, Nakazawa T, Notohara K, et al. Intraductal papillary mucinous neoplasm associated with autoimmune pancreatitis. Pancreas. 2013;42:552–4.PubMed Naitoh I, Nakazawa T, Notohara K, et al. Intraductal papillary mucinous neoplasm associated with autoimmune pancreatitis. Pancreas. 2013;42:552–4.PubMed
4.
Zurück zum Zitat Urata T, Naito Y, Izumi Y, et al. Localized type 1 autoimmune pancreatitis superimposed upon preexisting intraductal papillary mucinous neoplasms. World J Gastroenterol. 2013;19:9127–32.PubMedPubMedCentral Urata T, Naito Y, Izumi Y, et al. Localized type 1 autoimmune pancreatitis superimposed upon preexisting intraductal papillary mucinous neoplasms. World J Gastroenterol. 2013;19:9127–32.PubMedPubMedCentral
5.
Zurück zum Zitat Bateman AC, Culver EL, Sommerlad M, et al. Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease? J Clin Pathol. 2013;66:671–5.PubMedPubMedCentral Bateman AC, Culver EL, Sommerlad M, et al. Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease? J Clin Pathol. 2013;66:671–5.PubMedPubMedCentral
6.
Zurück zum Zitat Tabata T, Kamisawa T, Hara S, et al. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease: a coincidental association. Pancreatology. 2013;13:379–83.PubMed Tabata T, Kamisawa T, Hara S, et al. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease: a coincidental association. Pancreatology. 2013;13:379–83.PubMed
7.
Zurück zum Zitat Vaquero EC, Salcedo MT, Cuatrecasas M, et al. Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases. Pancreatology. 2014;14:316–8.PubMed Vaquero EC, Salcedo MT, Cuatrecasas M, et al. Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases. Pancreatology. 2014;14:316–8.PubMed
8.
Zurück zum Zitat Hedayat AA, Lisovsky M, Suriawinata AA, et al. Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms. Pancreatology. 2017;17:263–6.PubMed Hedayat AA, Lisovsky M, Suriawinata AA, et al. Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms. Pancreatology. 2017;17:263–6.PubMed
9.
Zurück zum Zitat Koshita S, Noda Y, Ito K, et al. Branch duct intraductal papillary mucinous neoplasms of the pancreas involving type 1 localized autoimmune pancreatitis with normal serum IgG4 levels successfully diagnosed by endoscopic ultrasound-guided fine-needle aspiration and treated without pancreatic surgery. Intern Med. 2017;56:1163–7.PubMedPubMedCentral Koshita S, Noda Y, Ito K, et al. Branch duct intraductal papillary mucinous neoplasms of the pancreas involving type 1 localized autoimmune pancreatitis with normal serum IgG4 levels successfully diagnosed by endoscopic ultrasound-guided fine-needle aspiration and treated without pancreatic surgery. Intern Med. 2017;56:1163–7.PubMedPubMedCentral
10.
Zurück zum Zitat Roch AM, Rosati CM, Cioffi JL, et al. Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease? Am J Surg. 2016;211:512–8.PubMed Roch AM, Rosati CM, Cioffi JL, et al. Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease? Am J Surg. 2016;211:512–8.PubMed
11.
Zurück zum Zitat Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771–6.PubMed Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771–6.PubMed
12.
Zurück zum Zitat Seo N, Byun JH, Kim JH, et al. Validation of the 2012 International Consensus Guidelines using computed tomography and magnetic resonance imaging: branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2016;263:557–64.PubMed Seo N, Byun JH, Kim JH, et al. Validation of the 2012 International Consensus Guidelines using computed tomography and magnetic resonance imaging: branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2016;263:557–64.PubMed
13.
Zurück zum Zitat Hirono S, Kawai M, Okada KI, et al. Factors associated with invasive intraductal papillary mucinous carcinoma of the pancreas. JAMA Surg. 2017;152:e165054.PubMed Hirono S, Kawai M, Okada KI, et al. Factors associated with invasive intraductal papillary mucinous carcinoma of the pancreas. JAMA Surg. 2017;152:e165054.PubMed
14.
Zurück zum Zitat Kato N, Akiyama S, Motoyama T. Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas. Pyloric gland adenoma of the pancreas. Virchows Arch. 2002;440:205–8.PubMed Kato N, Akiyama S, Motoyama T. Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas. Pyloric gland adenoma of the pancreas. Virchows Arch. 2002;440:205–8.PubMed
Metadaten
Titel
Rare coincidence of intraductal papillary mucinous neoplasm and type 1 autoimmune pancreatitis
verfasst von
Rei Suzuki
Ryo Okada
Makoto Muto
Tadayuki Takagi
Mitsuru Sugimoto
Hiroki Irie
Jun Nakamura
Mika Takasumi
Tsunetaka Kato
Minami Hashimoto
Kenji Notohara
Osamu Suzuki
Yuko Hashimoto
Takuto Hikichi
Shigeru Marubashi
Hiromasa Ohira
Publikationsdatum
27.06.2020
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 6/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01162-z

Weitere Artikel der Ausgabe 6/2020

Clinical Journal of Gastroenterology 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.